St. Johns Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$496 Hold
1
﹤0.01% 186
2025
Q4
$584 Hold
1
﹤0.01% 185
2025
Q3
$488 Hold
1
﹤0.01% 195
2025
Q2
$408 Hold
1
﹤0.01% 191
2025
Q1
$500 Hold
1
﹤0.01% 185
2024
Q4
$522 Hold
1
﹤0.01% 199
2024
Q3
$621 Hold
1
﹤0.01% 219
2024
Q2
$554 Hold
1
﹤0.01% 187
2024
Q1
$582 Hold
1
﹤0.01% 197
2023
Q4
$532 Hold
1
﹤0.01% 179
2023
Q3
$507 Hold
1
﹤0.01% 176
2023
Q2
$522 Buy
+1
New +$540 ﹤0.01% 186
2021
Q3
Sell
-9
Closed -$5K 210
2021
Q2
$5K Buy
+9
New +$4.25K ﹤0.01% 143
2018
Q2
Sell
-150
Closed -$31K 198
2018
Q1
$31K Hold
150
0.02% 117
2017
Q4
$28K Hold
150
0.02% 108
2017
Q3
$28K Sell
150
-150
-50% -$27.2K 0.02% 130
2017
Q2
$52K Buy
+300
New +$50.4K 0.04% 103

Other funds holding TMO

St. Johns Investment Management's TMO Position: Q1 2026 in Review

St. Johns Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 1 share worth $496. The position accounts for ﹤0.01% of the portfolio, ranked #186.

St. Johns Investment Management first reported a position in TMO in Q2 2017 and has held it in 17 quarters since. The position peaked at $52K in Q2 2017. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • St. Johns Investment Management held 1 share of Thermo Fisher Scientific worth $496 as of Q1 2026.
  • St. Johns Investment Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of St. Johns Investment Management's portfolio in Q1 2026, its #186 holding.
  • St. Johns Investment Management first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 17 quarters since.
  • St. Johns Investment Management's Thermo Fisher Scientific position peaked at $52K in Q2 2017.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.